Small cell lung cancer extensive stage

• First-line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects with Extensive Stage Small Cell Lung Cance … Recruitment ended
  2024-511021-58-00 3 2022-08-02 "Extensive Stage Small cell lung cancer (ES-SCLC)"
• A study of lurbinectedin in combination with atezolizumab compared with atezolizumab as maintenance therapy in participants with extensive-s … Recruitment ended
  2023-503868-16-00 5 2022-02-14 "Small-Cell Lung Cancer (SCLC)"
• A study investigating what potential benefits adding AZD2811 might have to the current standard of care maintenance therapy of durvalumab in … Recruitment ended
  2024-511887-10-00 4 2021-09-14 "First-line patients with extensive disease small-cell lung c"
• A clinical study of pembrolizumab with other study treatments in people with refractory lung cancer (MK-3475-B98) Recruitment ended
  2023-507687-38-00 9 2021-08-23 "Participants with extensive-stage small cell lung cancer"
• A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Tarlatamab in Subjects With Small Cell Lung Cancer (DeLLphi-300 … Recruitment ended
  2023-506541-39-00 1 2018-08-03 "Small Cell Lung Cancer"
• Phase 1b Study of Tarlatamab in Combination with YL201 with or without Anti-PD-L1 in Subjects with Extensive Stage Small Cell Lung Cancer (D … Halted
  2024-515903-21-00 3 2025-10-31 "Extensive Stage Small Cell Lung Cancer (ES-SCLC)"
• A Study of BMS-986012 in Combination with Carboplatin, Etoposide, andNivolumab as First-line Therapy in Extensive-stage Small Cell Lung Canc … Ended
  2024-510700-36-00 4 2021-06-01 "Extensive-stage Small Cell Lung Cancer"
• A Study of Atezolizumab plus Carboplatin and Etoposide with or Without Tiragolumab (Anti-Tigit Antibody) in Patients with Untreated Extensiv … Ended
  2022-502988-37-00 5 2020-06-19 "Small cell lung cancer (SCLC)"
• A clinical study to test the safety (any good or bad effects) of CC-90011 in combination with standard of care (cisplatin and etoposide), on … Ended
  2023-509800-14-00 3 2019-02-25 "extensive stage small cell lung cancer"
• A trial of BMS-986012 in combination with chemotherapy for small cell lung cancer Ended
  2024-511824-15-00 9 2016-10-18 "Extensive-Stage Small Cell Lung Cancer"

Showing 25–34 of 34 trials